- Home
- CCSI vs CVRX Comparison
CCSI vs CVRX Comparison
Compare CCSI & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCSI
- CVRX
- Stock Information
- Founded
- CCSI 2021
- CVRX 2000
- Country
- CCSI United States
- CVRX United States
- Employees
- CCSI N/A
- CVRX N/A
- Industry
- CCSI Retail: Computer Software & Peripheral Equipment
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CCSI Technology
- CVRX Health Care
- Exchange
- CCSI Nasdaq
- CVRX Nasdaq
- Market Cap
- CCSI 475.1M
- CVRX 419.8M
- IPO Year
- CCSI N/A
- CVRX 2021
- Fundamental
- Price
- CCSI $23.51
- CVRX $12.98
- Analyst Decision
- CCSI Hold
- CVRX Strong Buy
- Analyst Count
- CCSI 5
- CVRX 7
- Target Price
- CCSI $27.20
- CVRX $17.83
- AVG Volume (30 Days)
- CCSI 155.8K
- CVRX 171.5K
- Earning Date
- CCSI 05-07-2025
- CVRX 04-29-2025
- Dividend Yield
- CCSI N/A
- CVRX N/A
- EPS Growth
- CCSI 17.26
- CVRX N/A
- EPS
- CCSI 4.62
- CVRX N/A
- Revenue
- CCSI $350,382,000.00
- CVRX $51,292,000.00
- Revenue This Year
- CCSI $1.26
- CVRX $27.21
- Revenue Next Year
- CCSI $0.88
- CVRX $25.87
- P/E Ratio
- CCSI $4.96
- CVRX N/A
- Revenue Growth
- CCSI N/A
- CVRX 30.53
- 52 Week Low
- CCSI $11.62
- CVRX $6.40
- 52 Week High
- CCSI $32.10
- CVRX $19.24
- Technical
- Relative Strength Index (RSI)
- CCSI 43.27
- CVRX 54.12
- Support Level
- CCSI $22.47
- CVRX $11.95
- Resistance Level
- CCSI $24.90
- CVRX $12.94
- Average True Range (ATR)
- CCSI 0.86
- CVRX 0.59
- MACD
- CCSI -0.01
- CVRX 0.18
- Stochastic Oscillator
- CCSI 43.95
- CVRX 83.18
About CCSI Consensus Cloud Solutions Inc.
Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in fax cloud business. The Company operates in USA, Canada, Ireland, and Other. Geographically, it derives a maximum revenue from the United States. The company's communication and digital signature solutions enable customers to securely and cooperatively access, exchange and use information across organizational, regional, and national boundaries.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.